Business · 24/01/2002Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for T-Scan 2000 Patent Extension
Summary
The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the patent extension of T-Scan 2000, a medical device, in accordance with federal regulations and law requirements.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →